Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 43 results for "ranjit kapadia"

Lupin: Earnings upgrades likely after stellar Q1

Experts bullish on Lupin after stellar Q1 performance

A Speaking to CNBC-TV18 post the result, Ranjit Kapadia of Centrum Broking expects Lupin to report a good performance on domestic front as well just like its peers Ranbaxy and Pfizer. He is highly bullish on the stocks backed by its strong Q1 ..., 1 month ago
Lupin: Earnings upgrades likely after stellar Q1 Smart Investor, 1 month ago

Sell Ranbaxy; Sun Pharma may test Rs 780: Ranjit Kapadia

Ranjit Kapadia of Centrum Broking is of the view that Sun Pharmaceutical Industries may test Rs 780.
 Money Control2 months ago Sun Pharma buys US drug maker  Smart Investor1 month ago Sun Pharma buys US-based injectable firm Pharmalucence  DNA India1 month ago Sun Pharma buys US injectables company  Hindu Business Line1 month ago
DNA India

IPCA Laboratories : Pharma cos may be hit by new price controls

Mumbai : The National Pharmaceutical Pricing Authority (NPPA) has fixed prices of ten combination drugs under Drugs Prices Control Order (DPCO), 2013. This is a part of a recent move taken by the NPPA to fix or revise prices in respect of 56 ...
 4 Traders2 days ago Fresh drug price control rule may hit Indian pharmaceutical companies  DNA India4 days ago Pharma companies shrug off price control, grow domestic business  DNA India1 week ago NPPA moves to bring cancer drugs under price control regime  4 Traders1 month ago

RANBAXY LABORATORIES : may face another hefty fine in the US of Rs 240 crore

NEW DELHI : Ranbaxy Laboratories may have to pay another hefty fine in the United States of close to Rs 240 crore , this time imposed by the State of Texas , people familiar with the matter told ET. The company has been in negotiation with the US ...
 4 Traders4 days ago Ranbaxy Laboratories may face another hefty fine in the US of Rs 240 crore  Economic Times1 week ago Ranbaxy overcharged Texas for drugs under its public-funded Medicaid programme: US Report  Economic Times1 week ago US slaps Rs 240-crore fine on Ranbaxy Laboratories over for fraud in its Medicaid programme  Economic Times1 week ago

Cipla expects growing tender biz not to hurt margins

Pharma major Cipla has said its proportion of low-margin tender business through government bids to the export sales may increase from less than 10% at present, but expects it will not have any adverse impact on its margins. Rajesh Garg, global ...
 DNA India1 week ago Cipla expects growing tender business not to hurt margins  DNA India5 days ago
Business Standard India

Sanofi India: Relief a few quarters away

Sanofi India's recent tie-up with Emcure Pharmaceuticals to jointly market their portfolio of anti-cancer drugs is positive. Although the stock has gained about four% since the tie-up news came, it will be a couple of quarters before the overhang of ...
 Business Standard India6 days ago

CBI may book Marans in Aircel case

The CBI is likely to file a charge sheet against former telecom minister Dayanidhi Maran and his brother Kalanidhi, the promoters of Sun Group, for alleged coercion in the takeover of Aircel by Malaysian company Maxis as Attorney General Mukul Rohatgi said ...
 Deccan Herald3 weeks ago

Final agenda for Techcircle Big Data Forum 2014; last few seats left; register now

Techcircle Big Data Forum 2014 to be held on August 7 at The Chancery Pavilion, Bangalore is just a day away. Register here With so much happening in the Big Data world, this unique conference is expected to provide latest insights on businesses ...
 Techcircle.in3 weeks ago

DR REDDY LABORATORIES : sees price cuts in injectables in US

Mumbai : Dr Reddy's Laboratories expects price cuts in some of its generic products in the US, notably in injectables space, as more rivals enter. Abhijit Mukherjee , chief operating officer, said the contribution from the injectable products ...
 4 Traders3 weeks ago Dr Reddy's sees big price cuts in injectables in US  DNA India4 weeks ago

Pfizer issues lock-out notice at Thane plant on disciplinary grounds

US drugmaker Pfizer Inc's Indian arm, on Friday, said it has issued a lock-out notice at its manufacturing facility at Navi Mumbai on the grounds of indiscipline and threats to management personnel. The factory has over 200-odd employees. ...
 DNA India1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less